Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: lapatinib ditosylate|RADIATION: radiation therapy|OTHER: laboratory biomarker analysis
Sponsor: Stanford University
Collaborators: National Cancer Institute (NCI)